0001179110-17-000942.txt : 20170113 0001179110-17-000942.hdr.sgml : 20170113 20170113180221 ACCESSION NUMBER: 0001179110-17-000942 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170113 DATE AS OF CHANGE: 20170113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001034842 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943248524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 MAIL ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duliege Anne-Marie CENTRAL INDEX KEY: 0001419579 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29889 FILM NUMBER: 17528815 MAIL ADDRESS: STREET 1: 4001 MIRANDA AVENUE CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 edgar.xml FORM 4 - X0306 4 2017-01-03 0 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001419579 Duliege Anne-Marie RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Common Stock 5000 D Common Stock 2017-01-03 4 S 0 5000 2.4055 D 0 D The Reporting Person purchased these shares on 12/31/16 under the Employee Stock Purchase Plan. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2016 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.36 to $2.44, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4. /s/ Dolly Vance (Attorney-in-Fact) 2017-01-13